MaxCyte, Inc. — Net Income by Fiscal Year

7 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/68d0f321-c44f-4641-a441-c821b836bd6b/serie/net-income

Fiscal yearNet IncomePeriodEvidence
FY 2025$-44.6M2025-01-01 – 2025-12-31evidence 0001104659-26-034557
FY 2024$-41.1M2024-01-01 – 2024-12-31evidence 0001558370-25-002721
FY 2023$-37.9M2023-01-01 – 2023-12-31evidence 0001558370-24-003001
FY 2022$-23.6M2022-01-01 – 2022-12-31evidence 0001558370-24-003001
FY 2021$-19.1M2021-01-01 – 2021-12-31evidence 0001558370-22-004081
FY 2020$-11.8M2020-01-01 – 2020-12-31evidence 0001558370-22-004081
FY 2019$-12.9M2019-01-01 – 2019-12-31evidence 0001558370-22-004081
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

MaxCyte, Inc. — all facts · Revenue · Operating Income